StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ)

Stock analysts at StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a research note issued to investors on Saturday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Price Performance

Enzo Biochem stock opened at $0.49 on Friday. Enzo Biochem has a 12-month low of $0.41 and a 12-month high of $1.30. The firm has a 50 day moving average of $0.57 and a 200 day moving average of $0.88.

Enzo Biochem (NYSE:ENZ) last issued its earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Trading of Enzo Biochem

A number of large investors have recently modified their holdings of the company. Mink Brook Asset Management LLC bought a new position in shares of Enzo Biochem in the 4th quarter worth $577,000. Wittenberg Investment Management Inc. raised its holdings in Enzo Biochem by 60.1% in the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after purchasing an additional 70,400 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of Enzo Biochem in the 4th quarter valued at about $35,000. Lepercq Multi Asset Fund purchased a new position in shares of Enzo Biochem in the 4th quarter worth approximately $88,000. Finally, Geode Capital Management LLC raised its stake in shares of Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after acquiring an additional 11,742 shares in the last quarter. Hedge funds and other institutional investors own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.